AZTA
Azenta, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$31.41
+0.74%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 613.8M | 593.8M | 573.4M | 665.1M | 555.5M |
| Cost of Revenue | 343.4M | 323.5M | 318.8M | 431.8M | 324.9M |
| Gross Profit | 270.4M | 270.3M | 254.6M | 233.3M | 230.6M |
| Operating Expenses | |||||
| R&D Expense | 35.7M | 30.4M | 31.5M | 34.0M | 27.5M |
| SG&A Expense | 255.5M | 251.2M | 253.1M | 281.5M | 227.1M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 513.0K | — | — | — | — |
| Total Operating Expenses | 291.8M | 281.5M | 284.6M | 315.5M | 254.6M |
| Cost and Expenses | 635.2M | 605.1M | 603.4M | 747.3M | 579.5M |
| Operating Income (EBIT) | (21.4M) | (11.3M) | (30.0M) | (82.2M) | (24.0M) |
| Non-Operating | |||||
| Interest Income | 18.3M | 18.8M | 33.2M | 43.7M | 20.3M |
| Interest Expense | — | — | — | — | 4.6M |
| Net Interest Income | 18.3M | 18.8M | 33.2M | 43.7M | 15.7M |
| Other Non-Op Income/Expense | (130.9M) | 4.1M | 10.9M | 51.8M | 14.1M |
| Non-Operating Income (excl Interest) | 130.9M | (4.1M) | (10.9M) | (51.8M) | (18.7M) |
| EBT (Pre-Tax Income) | (152.3M) | (7.1M) | (19.1M) | (30.4M) | (9.9M) |
| Income Tax Expense | (40.2M) | (31.6M) | 5.2M | (17.6M) | 1.4M |
| Bottom Line | |||||
| Net Income | (122.9M) | (55.8M) | (164.9M) | (14.3M) | (429.0M) |
| Earnings from Cont. Ops | (112.1M) | 24.5M | (24.4M) | (12.9M) | (11.3M) |
| Earnings from Discont. Ops | (10.8M) | (80.2M) | (140.5M) | (1.4M) | (417.7M) |
| Bottom Line Net Income | (122.9M) | (55.8M) | (164.9M) | (14.3M) | (429.0M) |
| Per Share | |||||
| Basic EPS | ($2.75) | ($1.22) | ($3.09) | ($0.22) | ($0.15) |
| Diluted EPS | ($2.76) | ($1.22) | ($3.09) | ($0.22) | ($0.15) |
| Revenue Per Share | $13.55 | $12.98 | $10.78 | $10.04 | $7.42 |
| Shares | |||||
| Basic Shares Outstanding | 45.3M | 45.7M | 53.2M | 66.3M | 74.9M |
| Diluted Shares Outstanding | 45.3M | 45.9M | 53.2M | 66.3M | 74.9M |
| Profitability Metrics | |||||
| EBITDA | (96.6M) | 54.1M | 71.6M | 55.2M | 48.4M |
| D&A | 55.6M | 61.2M | 90.7M | 85.6M | 53.7M |
| EBIT | (152.3M) | (7.1M) | (19.1M) | (30.4M) | (5.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026